newsfilter
← Latest News
GlobeNewswire·

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor "What This Means" Segment

Dr. Robert Schwartz, Chief Medical Officer of Autonomix, discusses the Company's recently announced results from the post hoc analysis of its proof-of-concept human clinical trial ("PoC 1") THE WOODLANDS, TX, Sept. 04,